Please login to the form below
New accounts: July
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period April to June 2005 inclusive.
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period April to June 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com
|
|  |
|  |
|
Alchemy |
Corporate |
Corporate |
Seven Stones |
|
Boehringer Ingelheim |
N/A |
N/A |
Dark Horse Agency |
|
Chiron Biopharma Europe |
N/A |
N/A |
Woolley Pau |
|
Ferring |
NPD |
Urology |
FCB Healthcare |
|
Genzyme |
Thyrogen |
Oncology |
Big Blue |
|
Gilead Sciences |
Emtriva |
HIV |
FCB HealthCare |
|
Gilead Sciences |
Truvada |
HIV |
FCB HealthCare |
|
Gilead Sciences |
Viread |
HIV |
FCB HealthCare |
|
Gilead (International) |
Corporate |
HIV |
FCB HealthCare |
|
GlaxoSmithKline |
New product |
Neurology |
Euro RSCG Life MSC |
|
Janssen-Cilag |
Lyrinel XL |
Urinary incontinence |
PBC Communications |
|
Novartis |
Zelnorm |
IBS |
The Medical Multimedia Company |
|
Novo Nordisk |
Diabetes insulin portfolio |
Diabetes |
Woolley Pau |
|
Orion Pharma |
Tridestra |
HRT |
Langland |
|
Orion Pharma |
Indivina |
HRT |
Langland |
|
Pfizer |
New product |
Ophthalmology |
The Medical Multimedia Company |
|
Roche Diagnostics |
Cobas |
Hospital in-vitro diagnostics |
PBC Communications |
|
Roche (International) |
NPD |
Haematology |
FCB HealthCare |
|
Trinity-Chiesi Pharmaceuticals |
New products |
Respiratory portfolio |
Swordfish Advertising |
Share
Related Hub content
Subscribe to our email news alerts
- Diversity and inclusion in clinical trials: keeping up momentum
- 10 Important Advisor Questions: Placement of Your Product in the Current/Future Treatment Algorithm
- Merck announces partnerships worth $1.3bn with BenevolentAI and Exscientia
- EC approves Menarini Group’s Orserdu for advanced or metastatic breast cancer
- Eli Lilly files US lawsuits over ‘unlawful’ sales of Mounjaro counterfeits
- Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma
No results were found
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
